Correction: Intestinal Ralstonia pickettii augments glucose intolerance in obesity (PLoS ONE (2017) 12:11 (e0181693) DOI: 10.1371/journal.pone.0181693);Intestinal Ralstonia pickettii augments glucose intolerance in obesity

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Udayappan, Shanthadevi D ^a   Kovatcheva Datchary, Petia ^b   Bakker, Guido J ^a   Havik, Stefan R ^a   Herrema, Hilde ^a   Cani, Patrice D ^c   Bouter, Kristien E ^a   Belzer, Clara ^d   Witjes, Julia J ^a   Vrieze, Anne ^a   De Sonnaville, Noor ^a   Chaplin, Alice ^a   Van Raalte, Daniel H ^e   Aalvink, Steven ^d   Dallinga Thie, Geesje M ^a   Heilig, Hans G H J ^d   Bergström, Göran ^b   Van Der Meij, Suzan ^f   Van Wagensveld, Bart A ^g   Hoekstra, Joost B L ^a   Holleman, Frits ^a   Stroes, Erik S G ^a   Groen, Albert K ^a,h   Bäckhed, Fredrik ^b,i   De Vos, Willem M ^a,d,j   Nieuwdorp, Max ^a,b,e   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Flevo Hospital   (Netherlands)

^g ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ Capital Region   (Denmark)

^j UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ENDOTOXIN; RNA 16S;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; DNA ISOLATION; DNA SEQUENCE; FECES; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; MESENTERIC FAT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PYROSEQUENCING; RALSTONIA PICKETTII; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; COMPLICATION; GRAM NEGATIVE INFECTION; INFLAMMATION; INTESTINE; INTRAABDOMINAL FAT; LIPID DIET; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

AGED; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DNA, BACTERIAL; FECES; FEMALE; GLUCOSE INTOLERANCE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFLAMMATION; INTESTINES; INTRA-ABDOMINAL FAT; MALE; MICE, INBRED C57BL; OBESITY; RALSTONIA PICKETTII;

EID: 85034833566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0192339     Document Type: Erratum

References (43)

1. Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet. 2010; 376(9754):1775–84. https://doi.org/10.1016/S0140-6736(10)61514-0 PMID: 21074255.
2. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015; 518(7538):187–96. https://doi.org/10.1038/nature14132 PMID: 25673412
3. Kredel LI, Siegmund B. Adipose-tissue and intestinal inflammation—visceral obesity and creeping fat. Front Immunol. 2014; 5:462. https://doi.org/10.3389/fimmu.2014.00462 PMID: 25309544
4. Fagerberg B, Kellis D, Bergstrom G, Behre CJ. Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women. J Intern Med. 2011; 269(6):636–43. https://doi.org/10.1111/j.1365-2796.2010.02336.x PMID: 21198995.
5. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, et al. Pro-inflammatory CD11c +CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010; 59(7):1648–56. https://doi.org/10.2337/db09-0287 PMID: 20357360
6. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010; 59(12):3049–57. https://doi.org/10.2337/db10-0253 PMID: 20876719
7. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013; 498(7452):99–103. https://doi.org/10.1038/nature12198 PMID: 23719380.
8. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500(7464):541–6. https://doi.org/10.1038/nature12506 PMID: 23985870.
9. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470–81. https://doi.org/10.2337/db07-1403 PMID: 18305141.
10. Clemente-Postigo M, Queipo-Ortuno MI, Murri M, Boto-Ordonez M, Perez-Martinez P, Andres-Lacueva C, et al. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res. 2012; 53(5):973–8. https://doi.org/10.1194/jlr.P020909 PMID: 22394503
11. Harte AL, Varma MC, Tripathi G, McGee KC, Al-Daghri NM, Al-Attas OS, et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care. 2012; 35(2):375–82. https://doi.org/10.2337/dc11-1593 PMID: 22210577
12. Sun L, Yu Z, Ye X, Zou S, Li H, Yu D, et al. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care. 2010; 33(9):1925–32. https://doi.org/10.2337/dc10-0340 PMID: 20530747
13. Gummesson A, Carlsson LM, Storlien LH, Backhed F, Lundin P, Lofgren L, et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity (Silver Spring). 2011; 19(11):2280–2. https://doi.org/10.1038/oby.2011.251 PMID: 21852815.
14. Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermudez-Humaran LG, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011; 3(9):559–72. https://doi.org/10.1002/emmm.201100159 PMID: 21735552
15. Ryan MP, Adley CC. Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis. 2014; 33(3):291–304. https://doi.org/10.1007/s10096-013-1975-9 PMID: 24057141.
16. Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S, et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia. 2011; 54(12):3055–61. https://doi.org/10.1007/s00125-011-2329-8 PMID: 21976140.
17. Brohall G, Behre CJ, Hulthe J, Wikstrand J, Fagerberg B. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care. 2006; 29(2):363–7. PMID: 16443888.
18. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012; 308(11):1150–9. https://doi.org/10.1001/2012.jama.11132 PMID: 22990274
19. Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143(4):913–6 e7. https://doi.org/10.1053/j.gastro.2012.06.031 PMID: 22728514.
20. Burcelin R, Serino M, Chabo C, Garidou L, Pomie C, Courtney M, et al. Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes Obes Metab. 2013; 15 Suppl 3:61–70. https://doi.org/10.1111/dom.12157 PMID: 24003922.
21. Carvalho FA, Koren O, Goodrich JK, Johansson ME, Nalbantoglu I, Aitken JD, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe. 2012; 12(2):139–52. https://doi.org/10.1016/j.chom.2012.07.004 PMID: 22863420
22. Chassaing B, Ley RE, Gewirtz AT. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology. 2014; 147(6):1363–77 e17. https://doi.org/10.1053/j.gastro.2014.08.033 PMID: 25172014
23. Cullender TC, Chassaing B, Janzon A, Kumar K, Muller CE, Werner JJ, et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe. 2013; 14(5):571–81. https://doi.org/10.1016/j.chom.2013.10.009 PMID: 24237702
24. Denou E, Lolmede K, Garidou L, Pomie C, Chabo C, Lau TC, et al. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Mol Med. 2015; 7(3):259–74. https://doi.org/10.15252/emmm.201404169 PMID: 25666722
25. Everard A, Geurts L, Caesar R, Van Hul M, Matamoros S, Duparc T, et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun. 2014; 5:5648. https://doi.org/10.1038/ncomms6648 PMID: 25476696
26. Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 2015; 519(7542):242–6. https://doi.org/10.1038/nature14115 PMID: 25533952
27. Geiger TL, Abt MC, Gasteiger G, Firth MA, O’Connor MH, Geary CD, et al. Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J Exp Med. 2014; 211 (9):1723–31. https://doi.org/10.1084/jem.20140212 PMID: 25113970
28. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med. 2011; 17(12):1585–93. https://doi.org/10.1038/nm.2505 PMID: 22101768
29. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116(11):3015–25. https://doi.org/10.1172/JCI28898PMID: 17053832
30. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328(5975):228–31. https://doi.org/10.1126/science.1179721 PMID: 20203013
31. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 2013; 502(7469):96–9. https://doi.org/10.1038/nature12503 PMID: 23995682
32. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979; 23 (2):403–11. PMID: 154474
33. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, et al. Mesen-teric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn’s disease. Gut. 2012; 61(1):78–85. https://doi.org/10.1136/gutjnl-2011-300370 PMID: 21940721
34. Ryan MP, Pembroke JT, Adley CC. Genotypic and phenotypic diversity of Ralstonia pickettii and Ralstonia insidiosa isolates from clinical and environmental sources including High-purity Water. Diversity in Ralstonia pickettii. BMC Microbiol. 2011; 11:194. https://doi.org/10.1186/1471-2180-11-194 PMID: 21878094
35. Glassing A, Dowd SE, Galandiuk S, Davis B, Chiodini RJ. Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathog. 2016; 8:24. https://doi.org/10.1186/s13099-016-0103-7 PMID: 27239228
36. Shi L, Li M, Miyazawa K, Li Y, Hiramatsu M, Xu J, et al. Effects of heat-inactivated Lactobacillus gasseri TMC0356 on metabolic characteristics and immunity of rats with the metabolic syndrome. Br J Nutr. 2013; 109(2):263–72. https://doi.org/10.1017/S000711451200116X PMID: 22717016.
37. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002; 68(7):3401–7. https://doi.org/10.1128/AEM.68.7.3401-3407.2002 PMID: 12089021
38. Rajilic-Stojanovic M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011; 141(5):1792–801. https://doi.org/10.1053/j.gastro.2011.07.043 PMID: 21820992.
39. Heilig HG, Zoetendal EG, Vaughan EE, Marteau P, Akkermans AD, de Vos WM. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol. 2002; 68(1):114–23. https://doi.org/10.1128/AEM.68.1.114-123.2002 PMID: 11772617
40. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010; 7(5):335–6. https://doi.org/10.1038/nmeth.f.303 PMID: 20383131
41. Zwielehner J, Lassl C, Hippe B, Pointner A, Switzeny OJ, Remely M, et al. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One. 2011; 6(12):e28654. https://doi.org/10.1371/journal.pone.0028654 PMID: 22194876
42. Bergmark L, Poulsen PH, Al-Soud WA, Norman A, Hansen LH, Sorensen SJ. Assessment of the specificity of Burkholderia and Pseudomonas qPCR assays for detection of these genera in soil using 454 pyrosequencing. FEMS Microbiol Lett. 2012; 333(1):77–84. https://doi.org/10.1111/j.1574-6968.2012.02601.x PMID: 22639954.
43. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akker-mansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013; 110(22):9066–71. https://doi.org/10.1073/pnas.1219451110 PMID: 23671105